Rubicon Research Limited (NSE:RUBICON)
India · Delayed Price · Currency is INR 1,556.00
+35.80 (2.35%)
At close: Jul 27, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 256.35 billion as of July 27, 2026.
Market Cap
256.35B
Enterprise Value
256.00B
Revenue
17.54B
Ranking
n/a
PE Ratio
101.63
Stock Price
1,556.00
ChartMarket Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 256.35B, an increase of 147.69%. That is a compound annual growth rate of 220.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 256.35B | 128.57% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 595.05B |
| GlaxoSmithKline Pharmaceuticals | 425.76B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 208.78B |
| AstraZeneca Pharma India | 204.20B |
| Caplin Point Laboratories | 199.39B |
| Jubilant Pharmova | 154.95B |
| CORONA Remedies | 129.23B |